Table 2.
Clinical Characteristics of the 12 Known Listeria Peritonitis Cases Reported in the United States
| Reference | Age/sex | Underlying Disease | Blood Culture | Ascitic Fluid WBC/mm3 | % granulocytes | Empiric Treatment | Narrowed Treatment | Outcome |
|---|---|---|---|---|---|---|---|---|
| Adeonigbagbe et al. 20009 | 73 / male | Liver metastases | Negative | 171 | 69 | Ampicillin-sulbactam | Ampicillin-sulbactam | Died |
| Curosh et al. 198912 | 69 / male | Cirrhosis, AAT Deficiency | Negative | 2100 | 51 | Cephapirin, Gentamicin | Ampicillin | Survived |
| Rheingold et al. 197717 | 44 / male | Cirrhosis, Hepatitis C and Alcohol | Positive | 9460 | 76 | Ceftriaxone, Metronidazole | Ampicillin | Survived |
| Rheingold et al. 197717 | 52 / female | Cirrhosis, Hepatitis C | Positive | 510 | 84 | Cefotaxime | Ampicillin-sulbactam | Survived |
| Yecies et al. 201320 | 66 / male | Cirrhosis, Hepatitis C | Negative | 3168 | 33 | Cefotaxime | Ampicillin | Died |
| Frachtman et al. 200923 | 49 / male | Cirrhosis, Alcohol | Positive | 1720 | 90 | Ampicillin | Cephazolin | Survived |
| Jayaraj et al. 199824 | 63 / male | Cirrhosis, Alcohol | Positive | 1100 | 57 | Ampicillin | Ampicillin | Survived |
| Nguyen et al. 199425 | 70 / female | Cirrhosis, Hepatitis C | Positive | 14,987 | NR | TMP-SMX | Ampicillin | Survived |
| Sivalingam et al. 199226 | 64 / male | Cirrhosis, Alcohol | Positive | 7200 | 78 | Ampicillin | Ampicillin+Amikacin | Died |
| Soto-Hernandez et al. 198827 | 72 / female | Cirrhosis, Autoimmune | Positive | 2,889 | NR | Ceftriaxone, Vancomycin | Ampicillin-sulbactam | Died |
| Tablang 200828 | 62 / male | Cirrhosis, Alcohol | Negative | 6000 | 86 | Cefotaxime | Ampicillin-sulbactam | Survived |
| Present Case | 68 / male | Cirrhosis, Alcohol and CKD | Negative | 2710 | 81 | Piperacillin-Tazobactam | Ampicillin-sulbactam | Survived |
NR: not reported; AAT: alpha anti-trypsin; CKD: chronic kidney disease; TMP-SMX: trimethoprim-sulfamethoxazole